CVE:SQD

SQI Diagnostics Stock Forecast, Price & News

C$0.18

-0.03 (-12.50 %)

(As of 07/26/2021 02:32 PM ET)

Add

Compare

Today's Range

C$0.17

▼

C$0.19

50-Day Range

C$0.17

▼

C$0.26

52-Week Range

C$0.15

▼

C$0.55

Volume260,775 shs

Average Volume148,645 shs

Market CapitalizationC$63.44 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive SQD News and Ratings via Email

Sign-up to receive the latest news and ratings for SQI Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

About SQI Diagnostics

SQI Diagnostics Inc., a precision medicine company, discovers, develops, produces, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company provides advanced diagnostics targeting organ transplant, autoimmune disease, and serological testing. It also offers TOR-dx, a lung panel test, which enables surgeon to assess the health of donor's lung; and COVID-19 at-home antibody test kit, and the RALI-Dx and RALI-fast point-of care tests to triage COVID-19 patients for respiratory distress. SQI Diagnostics Inc. was founded in 1999 and is headquartered in Toronto, Canada.

SQI Diagnostics Announces Proposed Insider Sales and Warrant Exercises to Fund Company
February 10, 2021 | markets.businessinsider.com

SQI Diagnostics Inc Stock , SQIDF
December 26, 2020 | markets.businessinsider.com

News for SQI Diagnostics Inc
December 25, 2020 | markets.businessinsider.com

North America Autoimmune Disease Diagnostics Market Estimated To Exceed 6.5 Billion Dollars By 2026
December 18, 2020 | marketwatch.com

Worldwide Autoimmune Disease Diagnosis Industry to 2025 - Impact Analysis of COVID-19
December 11, 2020 | marketwatch.com

Localized Autoimmune Disease Diagnostics Market 2021 Global Size, Growth Insight, Share, Trends, Industry Key Players, Regional Forecast To 2026
December 11, 2020 | marketwatch.com

SQI Diagnostics Reports Third Quarter 2020 Results
August 27, 2020 | finance.yahoo.com

IIROC Trading Resumption - SQD
August 18, 2020 | markets.businessinsider.com

How Much Are SQI Diagnostics Inc. (CVE:SQD) Insiders Spending On Buying Shares?
August 12, 2020 | finance.yahoo.com

SQI Diagnostics Inc.
April 25, 2020 | www.barrons.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange CVE
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolCVE:SQD
Previous Symbol
CUSIPN/A
CIKN/A
Websqidiagnostics.com
Phone+1-416-6749500
Employees147,000
Year FoundedN/A

Sales & Book Value

Annual SalesC$1.03 million
Price / Sales61.90
Cash FlowC$0.01 per share
Price / Cash Flow18.18
Book ValueC$0.01 per share
Price / Book21.88

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares362,530,000
Market CapC$63.44 million
Next Earnings Date8/26/2021 (Estimated)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.54 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for SQI Diagnostics.

2.7 Community Rank

Outperform Votes
SQI Diagnostics has received 81 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
SQI Diagnostics has received 71 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
SQI Diagnostics has received 53.29% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about SQI Diagnostics and other stocks. Vote “Outperform” if you believe SQD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SQD will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
SQI Diagnostics does not currently pay a dividend.
Dividend Growth
SQI Diagnostics does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, SQI Diagnostics insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of SQI Diagnostics is -4.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of SQI Diagnostics is -4.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
SQI Diagnostics has a P/B Ratio of 21.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

SQI Diagnostics (CVE:SQD) Frequently Asked Questions

What stocks does MarketBeat like better than SQI Diagnostics?

Wall Street analysts have given SQI Diagnostics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but SQI Diagnostics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is SQI Diagnostics' next earnings date?

SQI Diagnostics is scheduled to release its next quarterly earnings announcement on Thursday, August 26th 2021.
View our earnings forecast for SQI Diagnostics.

How were SQI Diagnostics' earnings last quarter?

SQI Diagnostics Inc. (CVE:SQD) released its earnings results on Friday, May, 21st. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.32 million for the quarter.
View SQI Diagnostics' earnings history.

How has SQI Diagnostics' stock been impacted by Coronavirus?

SQI Diagnostics' stock was trading at C$0.08 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SQD shares have increased by 133.3% and is now trading at C$0.18.
View which stocks have been most impacted by COVID-19.

Who are SQI Diagnostics' key executives?

SQI Diagnostics' management team includes the following people:

Dr. Clive J. Beddoe, Chair of the Board of Directors & Interim CEO (Age 74)
Mr. Morlan Reddock C.F.A., CPA, CGA, M.B.A., CFO & VP of Admin.
Dr. Eric Brouwer, Chief Scientific Officer & Director
Dr. Peter Lea Ph.D., Founder (Age 76)
Mr. Russell Peloquin, VP of Global Commercial Operations

Who are some of SQI Diagnostics' key competitors?

Some companies that are related to SQI Diagnostics include Oncimmune (ONC), Verici Dx (VRCI), Profound Medical (PRN), Yourgene Health (YGEN), LexaGene (LXG), Cambridge Cognition (COG), VentriPoint Diagnostics (VPT), Abingdon Health (ABDX), genedrive (GDR), GeneNews (GEN), LED Medical Diagnostics (LMD), Deepmatter Group (DMTR), Imaging Dynamics (IDL), Integrated Diagnostics (IDHC) and 3D Signatures (DXD).
View all of SQD's competitors.

What other stocks do shareholders of SQI Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SQI Diagnostics investors own include Cigna (CI), Global Payments (GPN), Alarm.com (ALRM), Brookfield Asset Management (BAM.A), Baxter International (BAX), Becton, Dickinson and (BDX), Charter Communications (CHTR), Costco Wholesale (COST), Canadian Tire (CTC.A) and CytRx (CYTR).

What is SQI Diagnostics' stock symbol?

SQI Diagnostics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SQD."

How do I buy shares of SQI Diagnostics?

Shares of SQD and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is SQI Diagnostics' stock price today?

One share of SQD stock can currently be purchased for approximately C$0.18.

How much money does SQI Diagnostics make?

SQI Diagnostics has a market capitalization of C$63.44 million and generates C$1.03 million in revenue each year.

How many employees does SQI Diagnostics have?

SQI Diagnostics employs 147,000 workers across the globe.

What is SQI Diagnostics' official website?

The official website for SQI Diagnostics is sqidiagnostics.com.

Where are SQI Diagnostics' headquarters?

SQI Diagnostics is headquartered at 36 Meteor Dr, ETOBICOKE, ON M9W 1A4, Canada.

How can I contact SQI Diagnostics?

SQI Diagnostics' mailing address is 36 Meteor Dr, ETOBICOKE, ON M9W 1A4, Canada. The company can be reached via phone at +1-416-6749500.

This page was last updated on 7/27/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

SQI Diagnostics Stock Forecast, Price & News

About SQI Diagnostics

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

2.7 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth